Company Achieved 50% YoY Revenue Growth &
Positive EBITDA
CALGARY,
AB, Nov. 21, 2024 /CNW/ - Nanalysis Scientific
Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA:
1N1), a leader in portable NMR machines and MRI technology for
industrial and research applications announces third quarter
results for the period ending on September
30, 2024, achieving 50% year-over-year revenue growth to
$10.6 million in Q3. Chief
Executive Officer Sean Krakiwsky and Chief Financial
Officer Randall McRae will host a conference call
at 5 P.M. Eastern Time today to discuss the results.
A second call will be held for European investors at 8:30am
Eastern Time tomorrow, November
22nd. All interested parties are invited to join
these calls. All dollar figures in this press release are in
thousands of Canadian dollars, except per share amounts or unless
otherwise stated.
"We continue to see strength in both of our core business
segments, product sales and security services," said Sean
Krakiwsky, Founder and CEO of Nanalysis. "We had a solid Q3,
as demonstrated by our year over year revenue growth. Within
Benchtop NMR we experienced our typical seasonal slowdown in the
third quarter. This was partially offset, however, by a large
medical imaging sale in the quarter. Our focus on efficiencies in
both our manufacturing processes and service delivery is resulting
in gross margin improvements and positive EBITDA."
Financial highlights for the three months
ended September 30, 2024:
|
|
Three months ended
September 30
|
($000's)
|
|
2024
|
2023
|
($)
Change
|
Change
|
Product
sales
|
|
4,242
|
3,941
|
301
|
8 %
|
Service
revenue
|
|
5,420
|
2,629
|
2,791
|
106 %
|
Flow-through
inventory
|
|
908
|
466
|
442
|
95 %
|
Total sales and
revenue
|
|
10,570
|
7,036
|
3,534
|
50 %
|
|
|
|
|
|
|
Gross margin percentage
- product sales
|
|
52 %
|
41 %
|
11 %
|
|
Gross margin percentage
- service revenue
|
|
15 %
|
-3 %
|
18 %
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
|
264
|
(1,354)
|
1,618
|
|
|
|
|
|
|
|
Net
loss
|
|
(1,644)
|
(6,287)
|
4,643
|
74 %
|
- For the three months ended September 30, 2024, the
Company reported consolidated revenue of $10,570, an increase
of $3,534 or 50% from the comparative period in
2023.
- Gross margin percentage on product sales was 52% versus 41% for
the three months ended September 30, 2024. Improvement
in gross margin percentage for Benchtop NMR is materializing, as
average selling prices have improved and manufacturing cost
reductions started in 2023 and continued in 2024 are taking
effect.
- Security service gross margin percentage in the quarter was 15%
versus (3)% in prior year comparative period as the Company
completed the full transition of 100% of airports serviced to its
control from the incumbent provider in the first quarter of 2024
and expects to increase revenue and drive efficiency within this
business through 2024.
- Adjusted EBITDA for the three months ended September 30,
2024, was $264K versus an Adjusted EBITDA (loss) of
($1,354K) in the same period last
year. This improvement was driven primarily by full
transition of airports to the Company's control resulting in
increased security services revenue, the effect of cost reduction
initiatives, and slightly improved product sales over the prior
year. This was offset partially by a slight decrease in
third-party equipment sales.
- Net loss for the three months ended was $1,644K as
compared to the three-month loss for September 30,
2023, of $6,287K. The difference between Adjusted
EBITDA and Net loss includes a number of non-cash charges such as
depreciation and amortization. Included in Net loss for the
three months ended September 30,
2023, the Company recognized a one-time charge of
$2.8 million related to the
deconsolidation of its Quad subsidiary.
Quarterly Trend:
|
2024
|
2023
|
($000's)
|
Q3
|
Q2
|
Q1
|
Q4
|
Product
sales
|
4,242
|
5,402
|
4,216
|
5,450
|
Security service
revenue
|
5,420
|
5,265
|
4,723
|
3,362
|
Flow-through parts
revenue
|
908
|
807
|
2,223
|
988
|
Total
revenue
|
10,570
|
11,474
|
11,162
|
9,800
|
|
|
|
|
|
Adjusted
EBITDA
|
264
|
414
|
(362)
|
(774)
|
Net loss for the
period
|
(1,644)
|
(1,995)
|
(2,522)
|
(2,123)
|
- The Company has demonstrated continuous margin expansion in
Security service revenue quarter over quarter, driven by the
expansion of the Company's airport security maintenance business as
the Company took over more airports from the incumbent service
provider, ultimately taking over all airports in Q1 2024.
- The Company reported positive Adjusted EBITDA in the third
quarter of 2024 despite the seasonality effects of the slower
summer months. The Company expects this to continue as it works to
grow both product sales and security service revenue, while closely
managing costs.
- Net loss was $1,644 in Q3 2024.
Net losses are decreasing as the Company has successfully grown
revenue and implements cost reduction initiatives.
Recent strategic and operational highlights during and after the
third quarter of 2024 include:
- Margin Expansion in both business segments: The
Company was able to reap the benefits of cost cutting and drive
efficiencies to grow gross margins to 52%, up 11% year over year in
product sales and 15%, up 18% year over year in security services
from (3%) in the prior year.
- Consistent Revenue in Airport Security Maintenance
Business: The mix between scheduled maintenance,
unscheduled maintenance and project work will shift quarterly but
should provide a consistent balance of billing. The Company is
focused on improving its efficiency and planning related to service
delivery in order to increase margins through 2024 and into
2025.
- Medical Imaging: The Company completed another large
medical imaging hardware sale in the quarter contributing to strong
product sales in a traditionally slower quarter.
Outlook
"As we enter the fourth quarter, we have continued strong sales
and the hard work we have done to expand our margins is
materializing," said Sean Krakiwsky, Founder and CEO of
Nanalysis. "Growth initiatives within the Scientific
Equipment segment include the development and future launch of new
products, developing new software applications, and seeking
vertical market partnerships. Our market opportunity is expanding
as more industries conclude that NMR, combined with the small size
and portability of our products, is an excellent solution for their
analysis needs. As we evolve, it is likely that we will
reduce effort selling other companies' products, and increasingly
focus on sales of our own proprietary products and services.
"Within the Security Services segment, we are pursuing several
new customer opportunities to leverage our existing
capabilities.
"Overall, we continue to grow our sales and are laser focused on
operational improvements to reach our ultimate goal of
profitability. These trends will continue through the rest of the
year and into 2025. We have a positive outlook, are executing well,
and expect a strong fourth quarter to close out the year."
Conference Call:
Investors interested in participating in the live full year call
can dial 1-800-510-2154 or 437-900-0527-1350 from abroad. Investors
can also access the call online through a listen-only webcast here:
https://app.webinar.net/qArLoq1oXkG or on the
investor relations section of the Company's website HERE.
The webcast will be archived on the Company's investor relations
webpage for at least 90 days and a telephonic playback will be
available for seven days after the conference call by calling
1-888-660-6345 or 289-819-1450, conference ID # 14204.
Additionally, the Company will be hosting a Q&A session for
its European investors at 8:30am ET
tomorrow, Friday, November 22nd, which can be accessed by
the following link: Join the meeting
now
Non-IFRS and Supplementary Financial Measures
The Company prepares and reports its consolidated financial
statements in accordance with International Financial Reporting
Standards as issued by the International Accounting Standards
Board, as adopted by the Canadian Accounting Standards Board
("IFRS"). However, this press release may make reference to
certain non-IFRS measures including key performance indicators
used by management. These measures are not recognized measures
under IFRS and do not have a standardized meaning prescribed by
IFRS and are therefore unlikely to be comparable to similar
measures presented by other companies. Rather, these measures are
provided as additional information to complement those IFRS
measures by providing further understanding of the Company's
results of operations from management's perspective. Accordingly,
these measures should not be considered in isolation nor as a
substitute for analysis of the Company's financial information
reported under IFRS.
The Company uses Flow-through parts revenue, Security service
revenue, and Adjusted Earnings Before Interest, Tax, Depreciation
and Amortization ("Adjusted EBITDA") as non-IFRS measures, which
may be calculated differently by other companies. These non-IFRS
measure are used to provide investors with a supplemental measure
of the Company's operating performance and liquidity and thus
highlight trends in the Company's business that may not otherwise
be apparent when relying solely on IFRS measures. The Company also
believes that securities analysts, investors and other interested
parties frequently use non-IFRS measures in the evaluation of
companies in similar industries.
|
|
Three months
ended September 30
|
($000's)
|
|
2024
|
2023
|
($)
Change
|
Security services
revenue
|
|
5,420
|
2,629
|
2,791
|
Flow-through inventory
revenue
|
|
908
|
466
|
442
|
Total Service
Revenue
|
|
6,328
|
3,095
|
3,233
|
|
|
|
|
|
Security services
costs
|
|
4,627
|
2,708
|
1,919
|
Flow-through inventory
costs
|
|
908
|
466
|
442
|
Total Cost of
Services
|
|
5,535
|
3,174
|
2,361
|
|
|
Three months
ended September 30
|
($000's)
|
|
2024
|
2023
|
($)
Change
|
Net
loss
|
|
(1,644)
|
(6,287)
|
4,643
|
Business acquisition
costs and contingent consideration loss
|
|
5
|
184
|
(179)
|
Depreciation and
amortization expense
|
|
1,098
|
1,073
|
25
|
Finance
expense
|
|
341
|
289
|
52
|
Stock-based
compensation
|
|
181
|
281
|
(100)
|
Foreign exchange (gain)
loss
|
|
(141)
|
79
|
(220)
|
Loss on loss of control
of subsidiary
|
|
-
|
2,810
|
(2,810)
|
Loss from
associate
|
|
305
|
256
|
49
|
Impairment of associate
receivable
|
|
74
|
-
|
74
|
Restructuring
costs
|
|
42
|
82
|
(40)
|
Current income tax
(recovery) expense
|
|
(22)
|
13
|
(35)
|
Deferred income tax
expense (recovery)
|
|
25
|
(134)
|
159
|
Adjusted
EBITDA
|
|
264
|
(1,354)
|
1,618
|
Supplementary Financial Measures
The Company may also use supplementary financial measures which
are intended to be disclosed on a periodic basis to depict the
historical or expected future financial performance, cash position,
or cash flow of the Company, are not a non-IFRS measure, and are
not presented in the financial statements. The measures as
discussed in this press release include:
- Gross margin percentage, which is defined as either
(Product sales less Cost of product sold) divided by Product sales
or (Security services revenue less Security services costs) divided
by Security services revenue
About Nanalysis Scientific Corp. (TSXV:
NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. in operates two primary business
segments: Scientific Equipment and Security Services. Within its
Scientific Equipment business is what the Company terms "MRI and
NMR for industry". The Company develops and manufactures portable
Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for
laboratory and industrial markets. The NMReady-60™ was the first
full-feature portable NMR spectrometer in a single compact
enclosure requiring no liquid helium or any other cryogens. The
Company has followed-up that initial offering with new products and
continues to have a strong innovation pipeline. In 2020, the
Company announced the launch of its 100MHz device, the most
powerful and most advanced commercial compact NMR device ever
brought to market.
The Company's devices are used in many industries (oil and gas,
chemical, mining, pharma, biotech, flavor and fragrances,
agrochemicals, law enforcement, and more) as well as numerous
government and university research labs around the world. The
Company is working to expand into new global market opportunities
independently and with partners. With its partners, the
Company provides scientific equipment sales and maintenance
services globally.
In 2022 the Company was awarded a five-year, $160 million contract to provide maintenance
services for passenger screening equipment in Canadian
airports. This has resulted in expansion of the Company's
Security Services business. The Company is providing airport
security equipment maintenance services in each province and
territory of Canada. In addition, the Company provides
commercial security equipment installation and maintenance services
to a variety of customers in North America.
Notice regarding Forward Looking Statements and Legal
Disclaimer
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-third-quarter-2024-results-302313518.html
SOURCE Nanalysis Scientific Corp.